About Spheryx
Spheryx is a company based in New York (United States) founded in 2014. Spheryx has raised $1.78 million across 10 funding rounds from investors including HHS, America’s Seed Fund and National Science Foundation. Spheryx offers products and services including xSight, xCell, xStream, and Compliant Software Suite. Spheryx operates in a competitive market with competitors including Halo Labs, Biotrack, Nexceloms, TACount and Nexcelom Bioscience, among others.
- Headquarter New York, United States
- SectorsHealthcare
- Email••••••••
- Website spheryx.solutions
- Social LinkedIn
- Legal Name Spheryx, Inc
- Total Equity Funding$1.78M (USD)
in 10 rounds
- Latest Funding Round$675K (USD), Seed
Apr 2023
- InvestorsHHS
& 3 more
Products & Services of Spheryx
Spheryx offers a comprehensive portfolio of products and services, including xSight, xCell, xStream, and Compliant Software Suite.
Tool for holographic analysis of sub-visible particles in suspensions.
System for analyzing cell viability in biologic and research applications.
Service for characterizing particles in industrial and academic contexts.
Suite for user-friendly interface in holographic data processing.
Funding Insights of Spheryx
Spheryx has successfully raised a total of $1.78M across 10 strategic funding rounds. The most recent funding activity was a Seed round of $675 thousand completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.78M
- Total Rounds 10
- Last Round Seed — $675,000
- Investors Count 4
All 10 funding rounds of Spheryx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2023 | $675,000 | Seed | – | – | – |
| Dec 2018 | $525,000 | Seed | – | – | – |
| Sep 2016 | $1.27M | Grant | – | – | |
| Sep 2016 | $748,000 | Grant | – | – | |
| Apr 2016 | $318,318 | Grant | – | – | |
| Dec 2015 | – | Grant | – | – | |
| Oct 2015 | $575,763 | Seed | – | – | – |
| Jul 2015 | $179,999 | Grant | – | – | |
| May 2015 | $150,000 | Grant | – | – | |
| Mar 2015 | – | Seed | – | – | – |
4 investors in total: 4 institutional.
Investors in Spheryx
Spheryx has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, America’s Seed Fund and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the US Government | – | seedfund.nsf.gov | Alexandria, United States | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Research is conducted to advance translational science for health solutions. | – | ncats.nih.gov | Rockville, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Spheryx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Spheryx
5 people are tracked at Spheryx (4 in leadership, 1 in board & advisors).
| Name | Role | Group |
|---|---|---|
Laura Philips | President, Chairman & CEO | Leadership |
David Ruffner | VP, Research & Development | Leadership |
Nancy Pearson | Marketing Director | Leadership |
Jaroslaw M. Blusewicz | Director, Scientific Software Development | Leadership |
David G. Grier | Chair | Board & advisors |
Complete people profiles for Spheryx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Spheryx
3 dated milestones of Spheryx across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Spheryx is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $675K.
Competitors of Spheryx
Spheryx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Halo Labs, Biotrack, Nexceloms, TACount and Nexcelom Bioscience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| halolabs.com | 2010 | Burlingame, United States | $23.7M | – | Developer of subvisible particle analyzer for life science and materials applications | |
| biotrack.nl | 2011 | Leeuwarden, Netherlands | – | – | Rapid microbial detection and identification system | |
| cellometer.net | 2003 | Lawrence, United States | – | 98 | Specializes in automated cell counting and analysis expertise. | |
| tacount.com | 2009 | Herzliya, Israel | $2.5M | – | Specializes in imaging-based technology for microbiological testing. | |
| nexcelom.com | 2003 | Lawrence, United States | – | – | Automated cell counting and imaging solutions are developed for cytometry. | |
| nanoparticleanalyzer.com | 2013 | Torrance, United States | – | 14 | Nano-particle counters are manufactured for research and biomedical uses. | |
| bioavlee.com | 2014 | Wroclaw, Poland | $536,432 | 3 | Bacteria are identified rapidly using laser diffraction and neural networks. | |
| micro-identification.com | 2010 | San Clemente, United States | – | – | Optical devices for rapid microbial identification in samples are manufactured. | |
| colony-counter.com | 2005 | Strassberg, Germany | – | – | Automated colony counter for microbial analysis in laboratory and quality control settings. |
Detailed competitors of Spheryx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Spheryx
The website of Spheryx (spheryx.solutions) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 77.2% vs previous month
Latest news on Spheryx
Complete news archive for Spheryx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Spheryx
10 companies that operate in the same segment as Spheryx (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spheryx
Spheryx was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Spheryx is headquartered in New York, United States. It is registered at New York, New York, United States.
Spheryx is a funded company, having raised a total of $1.78M across 10 funding rounds to date.
Spheryx was founded in 2014 in New York, United States, within the analytical instruments sector. Patented technologies including Total Holographic Characterization and Holographic Video Microscopy are employed to create devices for non-destructive analysis of suspended particles such as colloidal microspheres, emulsion droplets, and nanoparticles. Precision and reproducibility are provided for applications in biopharmaceuticals, semiconductors, medical diagnostics, manufacturing controls, consumer products, and wastewater testing.
Spheryx's top competitors include Halo Labs, Spectradyne and Biotrack.
Spheryx offers xSight, xCell, xStream, and Compliant Software Suite.
Spheryx has 4 investors. Key investors include HHS, America’s Seed Fund, National Science Foundation, and National Center for Advancing Translational Sciences.
Spheryx operates through Spheryx, Inc.